Search Results - "Morden, J.P."

OC-0432: Evaluating the feasibility of sparing CNS structures to reduce acute fatigue from IMRT for head and neck cancer by Dean, J.A, Smyth, G, Morden, J.P, Hall, E, Harrington, K.J, Nutting, C.M, Gulliford, S.L

Get full text

A Guide to Adjusting Survival Time Estimates to Account for Treatment Switching in Randomised Controlled Trials by Latimer, N.R, Abrams, K.R, Lambert, P.C, Crowther, M.J, Wailoo, A.J, Morden, J.P, Akehurst, R.L, Campbell, M.J

Get full text

PRM13 Methods for Estimating Survival Benefits in the Presence of Treatment Crossover: A Simulation Study by Latimer, N, Lambert, P, Crowther, M, Abrams, K.R, Wailoo, A.J, Morden, J.P

Get full text

Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial by Gujral, D.M, Piercy, D, Morden, J.P, Emson, M, Hall, E, Miah, A.B, Bhide, S.A, Newbold, K.L, Harrington, K.J, Nutting, C.M

“…Summary Objectives Induction chemotherapy (IC) followed by chemoradiation (CRT) for locally advanced squamous cell head and neck cancer (SCCHN) remains…”
Get full text

MO1 - A Guide to Adjusting Survival Time Estimates to Account for Treatment Switching in Randomised Controlled Trials by Latimer, N.R., Abrams, K.R., Lambert, P.C., Crowther, M.J., Wailoo, A.J., Morden, J.P., Akehurst, R.L., Campbell, M.J.

Get full text

The Application and Feasibility of Using Routine Data Sources for Long-term Cancer Clinical Trial Follow-up by Bhattacharya, I.S., Morden, J.P., Griffin, C., Snowdon, C., Brannan, R., Bliss, J.M., Kilburn, L.

Get full text